Literature DB >> 12230909

Antistress and adaptogenic activity of lecithin supplementation.

Ratan Kumar1, Harish M Divekar, Vanita Gupta, Kaushal K Srivastava.   

Abstract

OBJECTIVE: Investigation of lecithin administration in rats for its antistress and adaptogenic activity.
DESIGN: Lecithin was administered orally (1 mg/g body weight) to rats 0.5 hour, 1.5 hours, 3.0 hours, and 6.0 hours prior to cold (5 degrees C)-hypoxia (428 mm Hg)-restraint (C-H-R) exposure and serum choline estimation. The rectal temperature (T(rec)) of the rats was monitored during the exposure and the recovery periods. The time for decrease of T(rec) to 23 degrees C and its recovery to 37 degrees C were used as indices of antistress and adaptogenic activity.
RESULTS: Lecithin administration 3-6 hours prior to C-H-R exposure was found to have significant adaptogenic activity that correlated with increased serum choline levels. Lecithin administration prior to C-H-R exposure increased the stress tolerance of the rats by delaying the time for decrease of T(rec) to 23 degrees C during C-H-R exposure. It also helped shorten poststress recovery as observed by decreased time to attain T(rec) of 37 degrees C from C-H-R-induced hypothermia (T(rec), 23 degrees C).
CONCLUSIONS: The results suggested that lecithin supplementation acted as an antistress and adaptogenic functional food. It improved resistance during C-H-R exposure and enhanced recovery from hypothermia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12230909     DOI: 10.1089/107555302760253685

Source DB:  PubMed          Journal:  J Altern Complement Med        ISSN: 1075-5535            Impact factor:   2.579


  2 in total

Review 1.  The effects of dietary choline.

Authors:  Elisabetta Biasi
Journal:  Neurosci Bull       Date:  2011-10       Impact factor: 5.203

2.  Anti-stress and Adaptogenic Activity of l-Arginine Supplementation.

Authors:  Vanita Gupta; Asheesh Gupta; Shalini Saggu; Harish M Divekar; S K Grover; Ratan Kumar
Journal:  Evid Based Complement Alternat Med       Date:  2004-12-08       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.